---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-086117"
form_type: "8-K"
ticker: "RBOT"
cik: "0001812173"
company_name: "Vicarious Surgical Inc."
filed_at: "2023-11-13T23:59:59+00:00"
generated_at: "2026-06-08T05:22:04.914116+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Vicarious Surgical Q3 loss $0.10 GAAP, delays system build to Fall 2024, De Novo to 2026

## Summary
- GAAP net loss $15.7M ($0.10/sh); adjusted net loss $20.4M ($0.12/sh).
- Cash $110M (incl. $47M equity proceeds); Q3 cash burn $16.8M. FY23 cash burn guidance $60-65M; FY24 preliminary $40-55M.
- Version 1.0 system build delayed to Fall 2024; De Novo submission now expected early-mid 2026 due to market and integration challenges.
- Operating expenses $21.4M, down 4% YoY; R&D $13.0M, G&A $6.9M, S&M $1.4M.

## SEC filing metadata
- accession: 0001213900-23-086117
- form_type: 8-K
- ticker: RBOT
- cik: 0001812173
- company_name: Vicarious Surgical Inc.
- filed_at: 2023-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812173/000121390023086117/0001213900-23-086117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812173/000121390023086117/ea188079-8k_vicarious.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-086117
- JSON: https://secwatch.observer/filing/0001213900-23-086117.json
- Plain text: https://secwatch.observer/filing/0001213900-23-086117.txt

## Key facts
- Earnings Releases
  Vicarious Surgical Inc. reported the quarter ended September 30, 2023 results: net income GAAP net loss for the third quarter was $15.7 million, equating to a net loss per share of $0.10, EPS net loss per share of $0.10. Guidance reaffirmed.
  - Period: the quarter ended September 30, 2023
  - Net income: GAAP net loss for the third quarter was $15.7 million, equating to a net loss per share of $0.10
  - EPS: net loss per share of $0.10
  - Guidance: reaffirmed
  - Result: reported results
  source text: Vicarious Surgical Reports Third Quarter 2023 Financial Results
  evidence_url: https://www.sec.gov/Archives/edgar/data/1812173/000121390023086117/0001213900-23-086117-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.